Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Astria Therapeutics, Inc. (ATXS)
|
|
| Cash Flow Statement |
|
|
|
| Standardized | As Reported |
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Net income | -12.6 | -11.2 | -13.3 | -12.0 | -11.3 | -15.3 | -9.5 | -7.9 |
| Stock-based compensation | 1.3 | 1.2 | 1.1 | 1.2 | 1.1 | 1.2 | 1.0 | 1.0 |
| Change in working capital [+] | 0.6 | -3.3 | 1.5 | 0.5 | -0.1 | 0.1 | 1.9 | -1.3 |
| Other current assets | 0.7 | -0.9 | -1.1 | -0.7 | 0.1 | 0.2 | 1.2 | -2.1 |
| Accounts payable | -0.1 | 0.1 | | -0.2 | 0.1 | -0.6 | 1.0 | 0.0 |
| Accrued expenses | 0.0 | -2.5 | 2.6 | 1.4 | -0.2 | 0.6 | -0.3 | 0.9 |
| Other operating activities | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 1.4 | 0.4 | 0.4 |
| Cash from operations | -10.7 | -13.3 | -10.7 | -10.2 | -10.1 | -12.6 | -6.3 | -7.7 |
| |
| Capital expenditures | 0.0 | 0.0 | 0.0 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| Purchases of property and equipment | | 0.0 | 0.0 | -0.1 | 0.0 | | | |
| Purchases of short-term investments, net | -57.9 | 195.0 | -135.1 | 2.0 | -6.8 | -27.1 | -39.0 | |
| Purchases of short-term investments | -207.0 | -95.9 | -178.5 | -52.7 | -83.2 | -81.7 | -78.0 | |
| Sales of short-term investments | 149.1 | 290.9 | 43.4 | 54.7 | 76.4 | 54.6 | 39.0 | |
| Cash from investing | -57.9 | 195.0 | -135.2 | 2.0 | -6.8 | -27.1 | -39.0 | 0.0 |
| |
| Issuance of common stock, net | | | 107.6 | | | | | |
| Option exercises | 0.3 | 0.0 | 0.1 | 0.0 | | | 0.0 | 0.0 |
| Other cash from financing | 0.5 | 0.1 | 12.8 | 24.4 | | | 0.0 | 0.0 |
| Cash from financing | 0.3 | 0.0 | 120.4 | 24.3 | 0.0 | 0.0 | 0.0 | 0.0 |
| |
| Free cash flow | -10.7 | -13.3 | -10.7 | -10.3 | -10.1 | -12.6 | -6.3 | -7.7 |
| Per share (diluted) | ($0.38) | ($0.47) | ($0.73) | ($0.75) | ($0.77) | ($0.96) | ($0.70) | ($0.60) |
| |
|